Synzyme Technologies, Inc.
Records under this name other than patents Synzyme Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Synzyme Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,048,967 | Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute Term ended Term ended Aug 3, 2018 · From the USPTO record | Term ended | Term ended Aug 3, 2018 | From the USPTO record |
| US 7,314,633 | Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof Lapsed on the fee record Ended Jan 1, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jan 1, 2016 | From the USPTO record |
| US 7,229,629 | Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof Lapsed on the fee record Ended Jun 12, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2015 | From the USPTO record |
| US 6,323,175 | Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute Lapsed on the fee record Ended Nov 27, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 27, 2013 | From the USPTO record |
| US 6,458,758 | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules Lapsed on the fee record Ended Oct 1, 2006 · From the USPTO record | Lapsed on the fee record | Ended Oct 1, 2006 | From the USPTO record |
| US 5,591,710 | Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute Term ended Term ended no later than Jan 7, 2017 · Low confidence | Term ended | Term ended no later than Jan 7, 2017 | Low confidence |
| US 5,725,839 | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI Term ended Term ended no later than Mar 10, 2018 · Low confidence | Term ended | Term ended no later than Mar 10, 2018 | Low confidence |
| US 5,741,893 | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules Term ended Term ended no later than Apr 21, 2018 · Low confidence | Term ended | Term ended no later than Apr 21, 2018 | Low confidence |
| US 5,767,089 | Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules Term ended Term ended no later than Jun 16, 2018 · Low confidence | Term ended | Term ended no later than Jun 16, 2018 | Low confidence |
| US 5,789,376 | Transfusions with stabilized hemoglobin covalently bound to a nitroxide or polymers thereof Term ended Term ended no later than Aug 4, 2018 · Low confidence | Term ended | Term ended no later than Aug 4, 2018 | Low confidence |